AP
ETON icon

Anchyra Partners’s Eton Pharmaceutcials ETON Stock Holding History

Anchyra Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+6,081
New +$178K 0.05% 297

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Anchyra Partners's ETON Position: Q2 2026 in Review

Anchyra Partners opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 6,081 shares worth $220K. The stake represents 0.05% of the portfolio and ranks #297 among its holdings.

54 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Anchyra Partners held 6,081 shares of Eton Pharmaceutcials worth $220K as of Q2 2026.
  • Eton Pharmaceutcials was a new Anchyra Partners position in Q2 2026.
  • Eton Pharmaceutcials made up 0.05% of Anchyra Partners's portfolio in Q2 2026, its #297 holding.
  • 54 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.